Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of AC-Hib Conjugate Vaccine in Infants
NCT01580033Phase 3Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Apr 2012
- Primary completion
- Sep 2012
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal groups a and c and haemophilus b conjugate vaccine in meningococcal infection, Haemophilus influenzae type b infection (Hib), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started Apr 2012; status: completed.
02
Drugs
meningococcal groups a and c and haemophilus b conjugate vaccine
03
Conditions
meningococcal infectionHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01580033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01580033.